99% Savings - Buy Just @1 Rs X
Glimepride (Ipca), a prescription drug, is manufactured in various forms such as Tablet. It is primarily used for the treatment of Diabetes.
Medical history of the patient along with age and gender determines the dosage of Glimepride (Ipca). Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Refer to the dosage section for a detailed discussion.
While these are the most often observed Glimepride (Ipca) side effects, there are can be others also. These have been listed below. Usually, these side effects of Glimepride (Ipca) go away soon, and do not persist beyond the duration of the treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
In addition, Glimepride (Ipca)'s effect is Moderate during pregnancy and Unknown for lactating mothers. Warnings related to Glimepride (Ipca)'s effects on the liver, heart and kidney, if any, have been listed below.
Glimepride (Ipca) is contraindicated in people with pre-existing medical conditions like Heart Disease, Liver Disease, Kidney Disease as it can result in adverse effects. Other contraindications of Glimepride (Ipca) have been discussed in the sections ahead.
Besides this, Glimepride (Ipca) may also have severe interaction with some medicines. A complete list of these interactions is given below.
You should also be aware that Glimepride (Ipca) is safe while driving, and is addiction.
Glimepride (Ipca) is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Glimepride (Ipca) safe for pregnant women?
Glimepride can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Glimepride right away. Take your doctor's advice before taking it again.
Is the use of Glimepride (Ipca) safe during breastfeeding?
In the absence of any scientific study about the side effects of Glimepride in breastfeeding women, information on safety of Glimepride is unavailable.
What is the effect of Glimepride (Ipca) on the Kidneys?
Glimepride may cause harmful effects on kidney. if you feel its having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Glimepride (Ipca) on the Liver?
There may be an adverse effect on the liver after taking Glimepride. If you observe any side effects on your body then stop taking this drug. Take this medicine again only if your doctor advises you to do so.
What is the effect of Glimepride (Ipca) on the Heart?
Side effects of Glimepride rarely affect the heart.
Glimepride (Ipca) should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Glimepride (Ipca) unless your doctor advises you to do so -
Is this Glimepride (Ipca) habit forming or addictive?
No, you will not get addicted to Glimepride (Ipca).
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can operate a vehicle or heavy machinery after taking Glimepride (Ipca) since it does not cause drowsiness.
Is it safe?
Glimepride (Ipca) is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, the use of Glimepride (Ipca) in mental disorders is not effective.
Interaction between Food and Glimepride (Ipca)
Information is not available on the interaction of any foods with Glimepride (Ipca), due to a lack of research on this.
Interaction between Alcohol and Glimepride (Ipca)
Consuming Glimepride (Ipca) with alcohol can have many serious effects on your body.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Amaryl (glimepiride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 272
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1156-1158